Home >> News >> Business >> Nuclear Medicine/ Radiopharmaceuticals Market : Global Industry Opportunities, Market Size, Market Share, Industry Outlook and Strategies 2017-2025

Nuclear Medicine/ Radiopharmaceuticals Market : Global Industry Opportunities, Market Size, Market Share, Industry Outlook and Strategies 2017-2025

Credence Research states the interest of a new study on Nuclear Medicine/ Radiopharmaceuticals Market . The Nuclear Medicine/ Radiopharmaceuticals Market  is expected to Exhibit Rapid Growth during the Forecast Period. The research report, named “Nuclear Medicine/ Radiopharmaceuticals Market – Growth, Future Prospects, and Competitive Analysis, 2018- 2026,” estimates the historical performance and the current standing of this market, emphasizing especially on the dynamics of the need and supply of Electronic Weighing Scales .

The study research also considers many sections of the global Nuclear Medicine/ Radiopharmaceuticals Market  completely on the basis of the product type and application, considering their current as well as historical performance across the globe. Moreover, the report also shows the growth trajectory of each of the sections, global as well as in each of the regional segments, representing a descriptive analysis of the overall industry.

[Browse full report: “Nuclear Medicine/ Radiopharmaceuticals Market  Size]

[For a bigger picture Try FREE sample of this report now!]

Market Insights: Nuclear medicine/ radiopharmaceuticals is a drug that can be used either for diagnostic or therapeutic purposes. Advantage such as targeted therapeutic irradiation with lower adverse effects and cost effective treatment option are prime factors that are driving the nuclear medicine/radiopharmaceuticals market growth. Nuclear medicine/ radiopharmaceuticals is segmented on the basis of application such as therapeutic (thyroid, oncology, bone metastasis and other applications) and diagnostics application (cardiology, thyroid, oncology and other therapeutic application). It is estimated that, therapeutic application will show fastest market growth during forecast period due to its advantages over the traditional drug therapies such as targeted therapeutic action and lower side effects. Radiopharmaceuticals applications in cardiology and oncology is anticipated to grow significantly during forecast period due to its increasing applicability in diagnosis of the disease; furthermore, growing prevalence of these disease will fuel the market growth. Radiopharmaceuticals market is categorized on the basis of type such as diagnostics radiopharmaceuticals (SPECT and PET) and therapeutic Radiopharmaceutical (beta emitter, alpha emitter and brachytherapy). It is observed that, in the base year 2016, diagnostic radiopharmaceutical is major revenue generating segment, due to the rising incidence of cancer and cardiac disease, improved affordability, more precise technique and advancement in PET and SPECT scan. Radiopharmaceuticals market is currently dominated by North America due to technological advancement, higher investment in R&D activities, presence of large number of biopharmaceutical industries and research institutes. However, Asia Pacific will show fastest market growth due to increasing government investments in the life sciences sector and increasing partnership of key players with local manufacturer, and rapidly expanding life science industries will witness phenomenal growth.

Leading Players:  Advanced Accelerator Applications S.A., Bayer AG, Bracco Imaging S.p.A., Cardinal Health, Inc., GE Healthcare, IBA Molecular Imaging, Lantheus Medical Imaging Inc., Mallinckrodt plc., Medtronic, plc., Nordion, Inc., NTP Radioisotopes SOC Ltd., Segami Corporation and others.

The study paper also speaks about the present as well as upcoming ventures in the global Nuclear Medicine/ Radiopharmaceuticals Market  at length, making this knowledge of special value for businesses, consultants, and stakeholders functional in this market.

Further, the report analyzes the competitive aspect of this market by reviewing the profiles of the key market participants in a bid to determine the current hierarchy.

The main purpose of this research study is to help the associates operating in the worldwide industry for Nuclear Medicine/ Radiopharmaceuticals Market  in planning active artifices and enhancing their decision-making techniques to gain a competitive edge over their challengers.

The report added new project SWOT analysis, investment feasibility analysis, and investment return analysis.

Key advantages

  • The research gives an in-depth analysis of the global Nuclear Medicine/ Radiopharmaceuticals Market , with running trends and future views, to elucidate the imminent investment pockets.
  • The quantitative study from 2017 to 2025 is demanded to enable the stakeholders to capitalize on prevailing market possibilities.
  • The report provides real historical figures for 2014 and year-on-year predictions from 2017 to 2025, considering 2017/2018 as a base.
  • Overall analysis of all geographical regions is presented to determine the general opportunities.

Nuclear Medicine/ Radiopharmaceuticals Market  key segments

  • By type
  • By technology
  • By end-user
  • By region

O North America

O Europe

O Asia-pacific

[For a bigger picture Try FREE sample of this report now!]

About Us

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Contact Us:

Credence Research Inc.

105 N 1st ST #429


CA 95103

United States

Toll Free (US/CANADA): +1-800-361-8290

Web: https://www.credenceresearch.com

Follow Us:Twitter

LinkedIn @ https://us.linkedin.com/company/credenceresearch


Leave a Reply

Your email address will not be published. Required fields are marked *